Immune-checkpoint blockade: the springboard for immuno-combination therapy
Gene Ther
.
2015 Nov;22(11):849-50.
doi: 10.1038/gt.2015.98.
Authors
A M Ibrahim
1
,
Y Wang
1
,
N R Lemoine
1
Affiliation
1
Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
PMID:
26537748
DOI:
10.1038/gt.2015.98
No abstract available
Publication types
Editorial
MeSH terms
Animals
Combined Modality Therapy
Humans
Immunotherapy / methods*
Neoplasms / drug therapy
Neoplasms / immunology*
Neoplasms / therapy*
Grants and funding
MR/M015696/1/MRC_/Medical Research Council/United Kingdom